Event Date/Time: Aug 08, 2002
End Date/Time: Aug 09, 2002
IBC’s inaugural conference on Model Organisms for Drug Discovery provides not only an up-to-date look at the latest tools, but also case sutides of model organism applications from the end-users. Leading industry companies such as AstraZeneca, Bristol-Myers Squibb and Millennium will discuss target validation using single and multiple model systems. Aventis, Ingenium Pharmaceuticals, Deltagen, and Bristol-Myers Squibb will present single and multiple models to validate targets across multiple target classes, to elucidate mechanisms of drug action and to develop assays for identifying lead compounds. In addition, a number of model system platforms including C.elegans, Drosophila, mice, yeast, and zebrafish will be presented.